Active Ingredient: VOXELOTOR
Proprietary Name: OXBRYTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N213137
Product Number: 001
Approval Date: Nov 25, 2019
Applicant Holder Full Name: GLOBAL BLOOD THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
